Melphalan flufenamide for relapsed/refractory multiple myeloma.
Drugs Today (Barc)
; 58(8): 407-423, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35983927
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Myeloma
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Drugs Today (Barc)
Journal subject:
MEDICINA OCUPACIONAL
/
SAUDE AMBIENTAL
Year:
2022
Type:
Article
Affiliation country:
United States